Elanco Animal Health Incorporated (ELAN) — Financial statements
Income statement, balance sheet, and cash flow for Elanco Animal Health Incorporated — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 4,715↑6.2% | 4,439↑0.5% | 4,417↑0.1% | 4,411↓7.4% | 4,764 | |
| Cost of Revenue | 2,665↑5.3% | 2,530↑2.1% | 2,479↑1.6% | 2,441↓9.2% | 2,688 | |
| Gross Profit | 2,050↑7.4% | 1,909↓1.5% | 1,938↓1.6% | 1,970↓5.1% | 2,076 | |
| Operating Expenses | ||||||
| R&D Expenses | 368↑7.0% | 344↑5.2% | 327↑1.9% | 321↓13.0% | 369 | |
| General & Administrative Expenses | 0.00↓100.0% | 1,072 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 236 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 1,430↑8.8% | 1,314↑2.3% | 1,285↑1.6% | 1,265↓9.8% | 1,403 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 1,798↑8.4% | 1,658↑2.9% | 1,612↑1.6% | 1,586↓10.5% | 1,772 | |
| Total Costs & Expenses | 4,463↑6.6% | 4,188↑2.4% | 4,091↑1.6% | 4,027↓9.7% | 4,460 | |
| Operating Results | ||||||
| Operating Income | 252↑0.4% | 251↓23.0% | 326↓15.1% | 384↑26.3% | 304 | |
| Depreciation & Amortization | 680↑2.7% | 662↓4.6% | 694↑1.8% | 682↓4.7% | 716 | |
| EBITDA | 676↓54.6% | 1,489↑764.7% | -224↓125.9% | 866↑111.7% | 409 | |
| EBIT | -4↓100.5% | 827↑190.1% | -918↓598.9% | 184↑159.9% | -307 | |
| Interest & Other Income | ||||||
| Net Interest Income | -175↑48.4% | -339↓22.4% | -277↓8.2% | -256↑3.0% | -264 | |
| Interest Income | 45 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 220↓35.1% | 339↑22.4% | 277↑8.2% | 256↓3.0% | 264 | |
| Non-Operating Income | 256↑144.4% | -576↓146.3% | 1,244↑522.0% | 200↓67.3% | 611 | |
| Other Income / Expenses | -476↓300.8% | 237↑115.6% | -1,521↓233.6% | -456↑47.9% | -875 | |
| Income Before Tax | -224↓145.9% | 488↑140.8% | -1,195↓1559.7% | -72↑87.4% | -571 | |
| Income Tax Expense | 8↓94.7% | 150↑316.7% | 36↑500.0% | 6↑106.8% | -88 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -232↓168.6% | 338↑127.5% | -1,231↓1478.2% | -78↑83.9% | -483 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -232↓168.6% | 338↑127.5% | -1,231↓1478.2% | -78↑83.9% | -483 | |
| Bottom-Line Net Income | -232↓168.6% | 338↑127.5% | -1,231↓1478.2% | -78↑83.9% | -483 | |
| EPS (Basic) | -0.47↓169.1% | 0.68↑127.2% | -2.50↓1566.7% | -0.15↑84.5% | -0.97 | |
| EPS (Diluted) | -0.47↓169.1% | 0.68↑127.2% | -2.50↓1566.7% | -0.15↑84.5% | -0.97 | |
| Weighted Average Shares | 496↑0.5% | 494↑0.3% | 492↑0.8% | 488↑0.2% | 487 | |
| Weighted Average Diluted Shares | 496↓0.2% | 497↑1.0% | 492↑0.8% | 488↑0.2% | 487 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.